{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:46:42Z","timestamp":1792507602858,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","award":["214261"],"award-info":[{"award-number":["214261"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Immune regulation status may indicate immunological remission in rheumatoid arthritis (RA). This cross-sectional study aimed to determine the Regulatory T cell (Treg) properties, together with 14 plasma cytokines levels between active RA and clinical remission patients. Peripheral blood (PB) Foxp3+ Treg was collected from RA patients for determination of Treg inhibitory activity using a co-culture system. Other PB T cell types and plasma cytokines were determined by flow-cytometry. The Treg results were analyzed according to the disease activity score-28 (DAS28). Then sensitivity and specificity were calculated for the indication of the remission status. The number and inhibitory activity of Treg are higher in the clinical remission as compared to the active RA (\n                    <jats:italic>p<\/jats:italic>\n                    value &lt;\u20090.0001). Also, Treg: CD4+CD25+CD127+ cell ratio demonstrates the similar result (\n                    <jats:italic>p<\/jats:italic>\n                    value &lt;\u20090.05). Treg inhibitory activity is inversely correlated with the DAS28. Specificity and positive likelihood ratio of inhibitory activity for indicating remission status are 92.31% (95% CI 63.97\u201399.81) and 11.14 (95% CI 1.67\u201374.14), respectively. Treg inhibitory activity is a promising prognostic marker and probably represents the immunological remission status in RA.\n                  <\/jats:p>","DOI":"10.1038\/s41598-020-76168-1","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T06:02:55Z","timestamp":1605247375000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Inhibitory activity of FOXP3+ regulatory T cells reveals high specificity for displaying immune tolerance in remission state rheumatoid arthritis"],"prefix":"10.1038","volume":"10","author":[{"given":"Korawit","family":"Kanjana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parawee","family":"Chevaisrakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ponpan","family":"Matangkasombut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karan","family":"Paisooksantivatana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Putthapoom","family":"Lumjiaktase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,13]]},"reference":[{"key":"76168_CR1","doi-asserted-by":"publisher","first-page":"S214","DOI":"10.1002\/art.11407","volume":"49","author":"J Fransen","year":"2003","unstructured":"Fransen, J., Stucki, G. & van Riel, P. L. C. M. Rheumatoid arthritis measures: Disease Activity Score (DAS), Disease Activity Score-28 (DAS28), Rapid Assessment of Disease Activity in Rheumatology (RADAR), and Rheumatoid Arthritis Disease Activity Index (RADAI). Arthritis Care Res. 49, S214\u2013S224. https:\/\/doi.org\/10.1002\/art.11407 (2003).","journal-title":"Arthritis Care Res."},{"key":"76168_CR2","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1136\/annrheumdis-2016-209201","volume":"75","author":"G Schett","year":"2016","unstructured":"Schett, G. et al. Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: Current evidence and future directions. Ann. Rheum. Dis. 75, 1428. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209201 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"76168_CR3","doi-asserted-by":"publisher","first-page":"R8","DOI":"10.1186\/ar2907","volume":"12","author":"J Ursum","year":"2010","unstructured":"Ursum, J., Bos, W. H., van Dillen, N., Dijkmans, B. A. & van Schaardenburg, D. Levels of anti-citrullinated protein antibodies and IgM rheumatoid factor are not associated with outcome in early arthritis patients: A cohort study. Arthritis Res. Ther. 12, R8\u2013R8. https:\/\/doi.org\/10.1186\/ar2907 (2010).","journal-title":"Arthritis Res. Ther."},{"key":"76168_CR4","doi-asserted-by":"publisher","first-page":"e0162306","DOI":"10.1371\/journal.pone.0162306","volume":"11","author":"T Morita","year":"2016","unstructured":"Morita, T. et al. The proportion of regulatory T cells in patients with rheumatoid arthritis: A meta-analysis. PLoS ONE 11, e0162306. https:\/\/doi.org\/10.1371\/journal.pone.0162306 (2016).","journal-title":"PLoS ONE"},{"key":"76168_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.0105-2896.2009.00848.x","volume":"233","author":"S Oh","year":"2009","unstructured":"Oh, S., Rankin, A. L. & Caton, A. J. CD4+CD25+ regulatory T cells in autoimmune arthritis. Immunol. Rev. 233, 97\u2013111. https:\/\/doi.org\/10.1111\/j.0105-2896.2009.00848.x (2009).","journal-title":"Immunol. Rev."},{"key":"76168_CR6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.smim.2013.10.009","volume":"25","author":"M Kleinewietfeld","year":"2013","unstructured":"Kleinewietfeld, M. & Hafler, D. A. The plasticity of human Treg and Th17 cells and its role in autoimmunity. Semin. Immunol. 25, 305\u2013312. https:\/\/doi.org\/10.1016\/j.smim.2013.10.009 (2013).","journal-title":"Semin. Immunol."},{"key":"76168_CR7","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1093\/rheumatology\/kel089","volume":"45","author":"CA Lawson","year":"2006","unstructured":"Lawson, C. A. et al. Early rheumatoid arthritis is associated with a deficit in the CD4+CD25 high regulatory T cell population in peripheral blood. Rheumatology 45, 1210\u20131217. https:\/\/doi.org\/10.1093\/rheumatology\/kel089 (2006).","journal-title":"Rheumatology"},{"key":"76168_CR8","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1002\/art.20499","volume":"50","author":"JMR van Amelsfort","year":"2004","unstructured":"van Amelsfort, J. M. R., Jacobs, K. M. G., Bijlsma, J. W. J., Lafeber, F. P. J. G. & Taams, L. S. CD4+CD25+ regulatory T cells in rheumatoid arthritis: Differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheumatism 50, 2775\u20132785. https:\/\/doi.org\/10.1002\/art.20499 (2004).","journal-title":"Arthritis Rheumatism"},{"key":"76168_CR9","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1002\/art.34477","volume":"64","author":"M Samson","year":"2012","unstructured":"Samson, M. et al. Brief report: Inhibition of interleukin-6 function corrects Th17\/Treg cell imbalance in patients with rheumatoid arthritis. Arthritis Rheum. 64, 2499\u20132503. https:\/\/doi.org\/10.1002\/art.34477 (2012).","journal-title":"Arthritis Rheum."},{"key":"76168_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1479-5876-7-89","volume":"7","author":"M Kmieciak","year":"2009","unstructured":"Kmieciak, M. et al. Human T cells express CD25 and Foxp3 upon activation and exhibit effector\/memory phenotypes without any regulatory\/suppressor function. J. Transl. Med. 7, 89\u201389. https:\/\/doi.org\/10.1186\/1479-5876-7-89 (2009).","journal-title":"J. Transl. Med."},{"key":"76168_CR11","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1084\/jem.20060772","volume":"203","author":"W Liu","year":"2006","unstructured":"Liu, W. et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J. Exp. Med. 203, 1701. https:\/\/doi.org\/10.1084\/jem.20060772 (2006).","journal-title":"J. Exp. Med."},{"key":"76168_CR12","doi-asserted-by":"publisher","DOI":"10.1080\/15321819.2019.1659813","author":"K Kanjana","year":"2019","unstructured":"Kanjana, K., Paisooksantivatana, K., Matangkasombut, P., Chevaisrakul, P. & Lumjiaktase, P. Efficient short-term expansion of human peripheral blood regulatory T cells for co-culture suppression assay. J. Immunoassay Immunochem. https:\/\/doi.org\/10.1080\/15321819.2019.1659813 (2019).","journal-title":"J. Immunoassay Immunochem."},{"key":"76168_CR13","doi-asserted-by":"publisher","first-page":"vi5","DOI":"10.1093\/rheumatology\/kes279","volume":"51","author":"J Kay","year":"2012","unstructured":"Kay, J. & Upchurch, K. S. ACR\/EULAR 2010 rheumatoid arthritis classification criteria. Rheumatology 51, vi5\u2013vi9. https:\/\/doi.org\/10.1093\/rheumatology\/kes279 (2012).","journal-title":"Rheumatology"},{"key":"76168_CR14","doi-asserted-by":"publisher","first-page":"6346","DOI":"10.4049\/jimmunol.0901773","volume":"183","author":"L Zhang","year":"2009","unstructured":"Zhang, L., Bertucci, A. M., Ramsey-Goldman, R., Burt, R. K. & Datta, S. K. Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-\u03b2-producing CD8+ Treg cells are associated with immunological remission of lupus. J. Immunol. 183, 6346. https:\/\/doi.org\/10.4049\/jimmunol.0901773 (2009).","journal-title":"J. Immunol."},{"key":"76168_CR15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ejr.2013.03.005","volume":"35","author":"N Abaza","year":"2013","unstructured":"Abaza, N., El-kabarity, R. H. & Abo-Shady, R. A. Deficient or abundant but unable to fight? Estimation of circulating FoxP3+ T regulatory cells and their counteracting FoxP3\u2212 in rheumatoid arthritis and correlation with disease activity. Egypt. Rheumatol. 35, 185\u2013192. https:\/\/doi.org\/10.1016\/j.ejr.2013.03.005 (2013).","journal-title":"Egypt. Rheumatol."},{"key":"76168_CR16","doi-asserted-by":"publisher","first-page":"276","DOI":"10.4110\/in.2017.17.5.276","volume":"17","author":"MK Jung","year":"2017","unstructured":"Jung, M. K., Kwak, J.-E. & Shin, E.-C. IL-17A-producing Foxp3(+) regulatory T cells and human diseases. Immune Netw. 17, 276\u2013286. https:\/\/doi.org\/10.4110\/in.2017.17.5.276 (2017).","journal-title":"Immune Netw."},{"key":"76168_CR17","doi-asserted-by":"publisher","first-page":"6532","DOI":"10.1182\/blood-2010-11-317321","volume":"117","author":"B Hoechst","year":"2011","unstructured":"Hoechst, B., Gamrekelashvili, J., Manns, M. P., Greten, T. F. & Korangy, F. Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells. Blood 117, 6532. https:\/\/doi.org\/10.1182\/blood-2010-11-317321 (2011).","journal-title":"Blood"},{"key":"76168_CR18","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1136\/annrheumdis-2013-204228","volume":"74","author":"T Wang","year":"2015","unstructured":"Wang, T. et al. Regulatory T cells in rheumatoid arthritis showed increased plasticity toward Th17 but retained suppressive function in peripheral blood. Ann. Rheum. Dis. 74, 1293. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204228 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"76168_CR19","doi-asserted-by":"publisher","first-page":"5610","DOI":"10.1073\/pnas.0308054101","volume":"101","author":"KM Huster","year":"2004","unstructured":"Huster, K. M. et al. Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets. Proc. Natl. Acad. Sci. USA 101, 5610\u20135615. https:\/\/doi.org\/10.1073\/pnas.0308054101 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76168_CR20","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3390\/ijms19030730","volume":"19","author":"GR Lee","year":"2018","unstructured":"Lee, G. R. The balance of Th17 versus Treg cells in autoimmunity. Int. J. Mol. Sci. 19, 730. https:\/\/doi.org\/10.3390\/ijms19030730 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"76168_CR21","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1182\/blood-2010-12-328187","volume":"118","author":"EJ Wehrens","year":"2011","unstructured":"Wehrens, E. J. et al. Functional human regulatory T cells fail to control autoimmune inflammation due to PKB\/c-akt hyperactivation in effector cells. Blood 118, 3538\u20133548. https:\/\/doi.org\/10.1182\/blood-2010-12-328187 (2011).","journal-title":"Blood"},{"key":"76168_CR22","doi-asserted-by":"publisher","first-page":"77110","DOI":"10.18632\/oncotarget.20363","volume":"8","author":"S Santagata","year":"2017","unstructured":"Santagata, S. et al. Targeting CXCR4 reverts the suppressive activity of T-regulatory cells in renal cancer. Oncotarget 8, 77110\u201377120. https:\/\/doi.org\/10.18632\/oncotarget.20363 (2017).","journal-title":"Oncotarget"},{"key":"76168_CR23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00296-012-2365-9","volume":"33","author":"JS Oh","year":"2013","unstructured":"Oh, J. S. et al. The effect of various disease-modifying anti-rheumatic drugs on the suppressive function of CD4+CD25+ regulatory T cells. Rheumatol. Int. 33, 381\u2013388. https:\/\/doi.org\/10.1007\/s00296-012-2365-9 (2013).","journal-title":"Rheumatol. Int."},{"key":"76168_CR24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1084\/jem.20040165","volume":"200","author":"MR Ehrenstein","year":"2004","unstructured":"Ehrenstein, M. R. et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNF\u03b1 therapy. J. Exp. Med. 200, 277. https:\/\/doi.org\/10.1084\/jem.20040165 (2004).","journal-title":"J. Exp. Med."},{"key":"76168_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10067-013-2352-x","volume":"33","author":"B Szalay","year":"2014","unstructured":"Szalay, B. et al. The impact of conventional DMARD and biological therapies on CD4+ cell subsets in rheumatoid arthritis: A follow-up study. Clin. Rheumatol. 33, 175\u2013185. https:\/\/doi.org\/10.1007\/s10067-013-2352-x (2014).","journal-title":"Clin. Rheumatol."},{"key":"76168_CR26","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nm.3085","volume":"19","author":"H Nie","year":"2013","unstructured":"Nie, H. et al. Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-\u03b1 in rheumatoid arthritis. Nat. Med. 19, 322. https:\/\/doi.org\/10.1038\/nm.3085 (2013).","journal-title":"Nat. Med."},{"key":"76168_CR27","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3109\/03009740903170823","volume":"39","author":"T Alan\u00e4r\u00e4","year":"2010","unstructured":"Alan\u00e4r\u00e4, T., Karstila, K., Moilanen, T., Silvennoinen, O. & Isom\u00e4ki, P. Expression of IL-10 family cytokines in rheumatoid arthritis: Elevated levels of IL-19 in the joints. Scand. J. Rheumatol. 39, 118\u2013126. https:\/\/doi.org\/10.3109\/03009740903170823 (2010).","journal-title":"Scand. J. Rheumatol."},{"key":"76168_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s41927-017-0001-8","volume":"1","author":"A Alunno","year":"2017","unstructured":"Alunno, A., Carubbi, F., Giacomelli, R. & Gerli, R. Cytokines in the pathogenesis of rheumatoid arthritis: New players and therapeutic targets. BMC Rheumatol. 1, 3. https:\/\/doi.org\/10.1186\/s41927-017-0001-8 (2017).","journal-title":"BMC Rheumatol."},{"key":"76168_CR29","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/cei.12179","volume":"174","author":"E Gonzalo-Gil","year":"2013","unstructured":"Gonzalo-Gil, E. et al. Transforming growth factor (TGF)-\u03b2 signalling is increased in rheumatoid synovium but TGF-\u03b2 blockade does not modify experimental arthritis. Clin. Exp. Immunol. 174, 245\u2013255. https:\/\/doi.org\/10.1111\/cei.12179 (2013).","journal-title":"Clin. Exp. Immunol."},{"key":"76168_CR30","doi-asserted-by":"publisher","first-page":"R75","DOI":"10.1186\/ar2704","volume":"11","author":"J Ursum","year":"2009","unstructured":"Ursum, J., Bos, W. H., van de Stadt, R. J., Dijkmans, B. A. C. & van Schaardenburg, D. Different properties of ACPA and IgM-RF derived from a large dataset: further evidence of two distinct autoantibody systems. Arthritis Res. Ther. 11, R75\u2013R75. https:\/\/doi.org\/10.1186\/ar2704 (2009).","journal-title":"Arthritis Res. Ther."},{"key":"76168_CR31","doi-asserted-by":"publisher","first-page":"e005246","DOI":"10.1136\/bmjopen-2014-005246","volume":"4","author":"I Hafstr\u00f6m","year":"2014","unstructured":"Hafstr\u00f6m, I. et al. Rheumatoid factor and anti-CCP do not predict progressive joint damage in patients with early rheumatoid arthritis treated with prednisolone: A randomised study. BMJ Open 4, e005246. https:\/\/doi.org\/10.1136\/bmjopen-2014-005246 (2014).","journal-title":"BMJ Open"},{"key":"76168_CR32","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1093\/rheumatology\/kes362","volume":"52","author":"S Hirata","year":"2013","unstructured":"Hirata, S. et al. A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study. Rheumatology 52, 1202\u20131207. https:\/\/doi.org\/10.1093\/rheumatology\/kes362 (2013).","journal-title":"Rheumatology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76168-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76168-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76168-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T18:02:48Z","timestamp":1670349768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76168-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,13]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["76168"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-76168-1","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.739051370.793588960","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,13]]},"assertion":[{"value":"24 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19789"}}